NSE
IPCA Laboratories LimitedIPCALAB
Ipca Laboratories is a vertically integrated pharma company.
| Key products | Branded generics (anti-malarial leader), APIs, formulations. |
|---|---|
| Geography | India plus exports. |
| Competitors | Sun Pharma, Cipla, Torrent. |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
Competitive landscape — the read
vs mapped peers| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | CIPLA | +₹1,527.1 Cr | 39 | — | +1 | +10 | 31 |
| 2 | ALKEM | +₹103.5 Cr | 33 | — | — | -2 | 6 |
| 3 | IPCALABThis | — | — | — | — | — | — |
| 4 | DRREDDY | +₹0 Cr | 4 | — | — | +14 | 32 |
| 5 | SUNPHARMA | +₹0 Cr | 6 | — | +2 | +9 | 27 |
| 6 | TORNTPHARM | +₹0 Cr | 2 | — | — | — | — |
| 7 | LUPIN | +₹0 Cr | 4 | — | — | — | — |
| 8 | ZYDUSLIFE | +₹0 Cr | 1 | — | — | — | — |
| 9 | AUROPHARMA | +₹0 Cr | 2 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
Timeline — IPCALAB day by day
- 2026-06-12FilingIPCA Laboratories Limited has informed the Exchange regarding a press release dated Jun 12, 2026, titled "LicePress Release
- 2026-06-09FilingIPCA Laboratories Limited has informed the Exchange about Copy of Newspaper PublicationCompliance
Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.
Filings that matter
- 2Press ReleaseNeutral
a press release dated Jun 12, 2026, titled "Licensing agreement granting Ipca access to BRL's proprietary high-concentration subcutaneous biologics delivery platform for the development and commercialization of multiple monoclonal antibody
Source PDF → - 1
No bulk/block deals for IPCALAB in this window.
News & chatter on IPCALAB
RSS News
0No recent news.
Google News RSS — links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.